UNITED STATES
                          SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549


                                   FORM 10-QSB


                   QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF
                        THE SECURITIES EXCHANGE ACT OF 1934

                   For the quarterly period ended March 31, 2003


                         Commission file number 0-14465




                              SONEX RESEARCH, INC.



                      Incorporated in the State of Maryland
                                23 Hudson Street
                            Annapolis, Maryland 21401


                        Telephone Number: (410) 266-5556
                   IRS Employer Identification No. 52-1188993






Check  whether the Issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the Exchange Act during the preceding 12 months, and (2) has been
subject to such filing requirements for the past 90 days.

                                            YES   [x]       NO   [ ]



There  were  21,592,669  shares  of the  Issuer's  $.01 par value  Common  Stock
outstanding at May 14, 2003.




                        SONEX RESEARCH, INC. FORM 10-QSB



                         PART I - FINANCIAL INFORMATION


ITEM 1.  FINANCIAL STATEMENTS (Unaudited)


Balance sheets as of March 31, 2003 and December 31, 2002

Statements of operations and  accumulated  deficit for the  three-month  periods
ended March 31, 2003 and 2002

Statements of paid-in  capital for the period  January 1, 2001 through March 31,
2003

Statements  of cash flows for the  three-month  periods ended March 31, 2003 and
2002

Notes to financial statements



































                              SONEX RESEARCH, INC.
                            CONDENSED BALANCE SHEETS
                                   (Unaudited)
                                                       March 31,   December 31,
                           ASSETS                        2003          2002
                                                     ------------  ------------
Current assets
 Cash and equivalents                                $    109,635  $    105,998
 Accounts receivable                                       23,601        64,702
 Prepaid expenses                                          27,633        25,814
 Loans to officers and employees                           22,500        22,500
                                                     ------------  ------------
   Total current assets                                   183,369       219,014

Patents and technology, net of accumulated amortization
  of $66,609 in 2003 and $60,909 in 2002                  198,885       203,623

Property and equipment, net of accumulated depreciation
 of $441,957 in 2003 and $438,357 in 2002                 106,138        58,808
                                                     ------------  ------------
           Total assets                              $    488,392  $    481,445
                                                     ============  ============

     LIABILITIES AND STOCKHOLDERS' EQUITY/(DEFICIT)

Current liabilities
 Accounts payable and other accrued liabilities      $     29,365  $     36,322
 Deferred revenue - billings in excess of costs
   and estimated profits on contracts in progress	    101,016	       66,587
 Current portion of capital lease obligations              14,760         5,657
 Notes and interest payable to shareholder                 36,681        37,327
 Accrued compensation and benefits                        426,687       427,397
                                                     ------------  ------------
     Total current liabilities                            608,509       573,290
                                                     ------------  ------------
Capital lease obligations                                  43,480		 10,985
                                                     ------------  ------------
Deferred compensation                                     922,433       906,856
                                                     ------------  ------------
Stockholders' equity/(deficit)
 Preferred stock, $.01 par value - 2,000,000
   shares issued; 1,540,001 shares outstanding             15,400        15,400
 Common stock, $.01 par value - shares issued
   and outstanding: 21,592,669 in 2003 and
   21,592,669 in 2002                                     215,927       215,927
 Additional paid-in capital                            21,446,408    21,420,742
 Accumulated deficit                                  (22,742,649)  (22,640,911)
 Notes receivable from officers and
   employees   	                                        (21,116)      (20,844)
                                                     ------------  ------------
   Total stockholders' equity/(deficit)                (1,086,030)   (1,009,686)
Commitments
                                                     ------------  ------------
   Total liabilities and stockholders' equity        $    488,392  $    481,445
                                                     ============  ============

    The accompanying notes are an integral part of the financial statements.
                              SONEX RESEARCH, INC.
           CONDENSED STATEMENTS OF OPERATIONS AND ACCUMULATED DEFICIT
                                   (Unaudited)




                                                Three months ended March 31,
                                              -------------------------------
                                                   2003                2002
                                              ------------        ------------

Revenue						    $	   174,329        $     35,870
                                              ------------        ------------

Costs and expenses
  Cost of revenue                                  108,426              32,998
  Research and development                          75,046              64,054
  General and administrative                        90,275              63,706
  Interest expense					     2,719			   784
                                              ------------        ------------
                                                   276,466		     161,542
                                              ------------        ------------

Net loss from operations                          (102,137)		    (125,672)

Investment income 						 399			     8
                                              ------------        ------------

Net loss                                          (101,738)		    (125,664)

Accumulated deficit

  Beginning of period                          (22,640,911)        (22,319,271)
                                              -------------       ------------

  End of period                               $(22,742,649)       $(22,444,935)
                                              ============        ============


Weighted average number of common
  shares outstanding                            21,592,669          21,224,669
                                              ============        ============


Net loss per share                                  $(.005)             $(.006)
                                                    ======              ======


   The accompanying notes are an integral part of the financial statements.







                              SONEX RESEARCH, INC.
                     CONDENSED STATEMENTS OF PAID-IN CAPITAL
                                   (Unaudited)


                          Price  Preferred stock    Common stock     Additional
                           per  ($.01 par value)  ($.01 par value)     paid-in
                          share  Shares   Amount   Shares    Amount    capital
                          ----- --------- ------ ---------- ------- -----------

Balance, January 1, 2001        1,540,001$15,400 19,479,868$194,799 $20,927,437

March private placement    $.25                     300,000   3,000      72,000
March for services          .25                      54,577     546      13,099
April private placement     .25                     125,000   1,250      30,000
June private placement      .20                     325,000   3,250      61,750
June for services           .29                      44,916     449      12,667
August payment of stock
 subscription               .20                      25,000     250       4,750
September for services      .25                      55,000     550      13,200
October private
 placement                  .15                     750,000   7,500     105,000
December for services       .25                      53,308     533      12,794
December forgiveness
 of payables                                                 		 10,000
Stock option compensation                                                42,120
Amortization of deferred
 compensation from grant of
 stock options                                       				 29,761
                                --------- ------ ---------- -------  ----------

Balance, December 31, 2001      1,540,001 15,400 21,212,669 212,127  21,334,577

March private placement     .15                     360,000   3,600      50,400
May for services            .25                      12,000     120       2,880
July for services           .25                       8,000      80       1,920
Stock option compensation                                                30,965
                                --------- ------ ---------- -------  ----------

Balance, December 31, 2002      1,540,001 15,400 21,592,669 215,927  21,420,742

Stock option compensation                                                25,666
                                --------- ------ ---------- -------  ----------

Balance, March 31, 2003         1,540,001$15,400 21,592,669$215,927 $21,446,408
                                ========= ====== ========== ======= ===========




    The accompanying notes are an integral part of the financial statements.






                              SONEX RESEARCH, INC.
                       CONDENSED STATEMENTS OF CASH FLOWS
                                   (Unaudited)

                                                           Three months ended
                                                                March 31,
                                                         ----------------------
                                                           2003          2002
                                                         --------      --------


Cash flows from operating activities
 Net loss                                             $   (101,738)  $ (125,664)
 Adjustments to reconcile net loss to
  net cash used by operating activities
   Depreciation                                              3,600	  4,200
   Amortization of patents                                   6,000	  4,800
   Compensation from grant of stock options  			25,666	  7,625
   Accrued interest on loans to/notes
     from employees                                 	        (272)
   Accrued interest on notes to shareholder                    681
   (Increase) decrease in accounts receivable               41,101	 11,958
   (Increase) decrease in prepaid expenses                  (1,819)	  1,896
   Increase (decrease) in accrued liabilities               (7,667)	 48,532
   Increase (decrease) in billings in excess of
     costs on contracts in progress                		34,429
   Increase (decrease) in deferred compensation             15,577	 12,681
                                                      ------------   -----------
Net cash provided by (used in) operating activities         15,558      (33,972)
                                                      ------------   -----------
Cash flows from investing activities
   Acquisition of property and equipment                    (7,928)
   Additions to patents and technology                      (1,262)	 (1,297)
                                                      ------------   ----------
Net cash provided by (used in) investing activities         (9,190)	 (1,297)
                                                      ------------   ----------
Cash flows from financing activities
   Issuance of convertible note							  6,000
   Payment of accrued interest on notes to
     shareholder								(1,327)
   Reduction of capital lease obligations 			(1,404)
   Issuance of stock - private placement                 			 54,000
                                                      ------------   ----------
Net cash provided by (used in) financing activities         (2,731)      60,000
                                                      ------------   ----------

Increase (decrease) in cash                                  3,637	 24,731

Cash
   Beginning of period                                     105,998        3,355
                                                      ------------   ----------
   End of period                                      $    109,635   $   28,086
                                                      ============   ==========


    The accompanying notes are an integral part of the financial statements.

                              SONEX RESEARCH, INC
                     NOTES TO CONDENSED FINANCIAL STATEMENTS
                                   (Unaudited)


NOTE 1 - THE COMPANY

Sonex Research, Inc. has developed a proprietary technology,  known as the Sonex
Combustion  System  (SCS),  which  improves the  combustion  of fuel in internal
combustion  engines through  modification of the pistons in large engines or the
cylinder  heads  in small  engines.  The SCS  achieves  in-cylinder  control  of
ignition and  combustion  to increase fuel mileage of gasoline  engines,  reduce
emissions of diesel engines,  and permit small gasoline  engines to run on safer
diesel-type  fuels. The Company's  objective is to execute broad agreements with
engine and parts manufacturers for industrial production of SCS components under
license from Sonex.


NOTE 2 - PRESENTATION OF FINANCIAL STATEMENTS

The accompanying  unaudited condensed financial statements have been prepared in
accordance with accounting principles generally accepted in the United States of
America for interim  financial  information  and with the  instructions  to Form
10-QSB  and  Item  310(b)  of  Regulation  S-B.  Accordingly,   these  financial
statements  do not  include all of the  information  and  footnotes  required by
generally accepted accounting principles for complete financial  statements.  In
the opinion of  management,  all  adjustments  (consisting  of normal  recurring
accruals) considered necessary for a fair presentation have been included.

Operating  results  for the  three-month  period  ended  March 31,  2003 are not
necessarily  indicative  of the results that may be expected for the year ending
December 31, 2003. For further  information,  reference is made to the financial
statements  and notes thereto  included in the  Company's  Annual Report on Form
10-KSB for the year ended December 31, 2002.

Certain  reclassifications  have been made to the  financial  statements  of the
prior year to conform to the  classifications  used in 2003,  most  notably  the
reclassification  of amounts in the  Statement of  Operations  from Research and
Development to Cost of Revenue.

The  costs  associated  with the  filing of patent  applications  are  deferred.
Amortization is recorded on a straight-line  basis over the remaining legal life
of patents, commencing in the year in which the patent is granted. Costs related
to patent applications which ultimately fail to result in the grant of a patent,
as well as the unamortized costs of patents abandoned by the Company due to lack
of expected  commercial  potential,  are charged to  operations at the time such
determination is made.

All of the Company's revenue for 2002 and 2003 has been derived from development
and  demonstration  contracts issued by a United States Government or Department
of Defense (the "Government") agency or prime contractor.  Revenue is recognized
upon the Company's  completion of the milestones  and/or  submission of progress
reports  specified in each contract.  Revenue and costs for these contracts that
require the Company to provide  stipulated  services for a fixed price have been
recognized using the  percentage-of-completion  method of accounting by relating
contract costs incurred to date to total estimated contract costs at completion.
In  connection  with  contracts in progress,  any excess of billings  over costs
incurred plus estimated  profits is recorded as a current  liability,  while any
excess of costs  incurred over billings is recorded as a current  asset,  at the
financial statement date.

For  fiscal  year  2003,  the  Company  changed  its  method of  accounting  for
stock-based compensation, as described in Note 9.


NOTE 3 - LIQUIDITY

Management  recognizes that the Company's history of operating losses,  level of
available funds, and revenue from current and future  contracts,  in relation to
projected  expenditures,  raise substantial doubt as to the Company's ability to
commence generation of significant  revenues from the  commercialization  of the
SCS and ultimately achieve profitable operations.  Accordingly, the Company will
continue to minimize its  operating  expenditures  through a number of measures,
including the ongoing  deferral by its officers of portions of their salaries as
described in Notes 5 and 7.

Based upon  available  resources,  current and projected  spending  levels,  and
expected revenue from current and anticipated contracts, management believes the
Company will have  sufficient  capital to fund operations  through  December 31,
2003. The Company's prospects beyond that date are dependent upon its ability to
enter into significant  funded contracts for the further  development of its SCS
technology,  establish  joint  ventures  or  strategic  partnerships  with major
industrial concerns,  or secure a major capital infusion.  There is no assurance
that the Company  will be able to achieve  these  objectives;  therefore,  there
remains  substantial  doubt about the  Company's  ability to continue as a going
concern.


NOTE 4 - NOTES PAYABLE TO SHAREHOLDER

In  connection  with a private  placement  in March 2002,  the Company  issued a
$6,000,  6% note,  initially  payable on June 30, 2002,  that is  convertible to
equity at the option of the holder.  The due date of the note has been  extended
several  times and is currently  due on June 30, 2003.  In July 2002 the Company
issued a $30,000,  8% note to this same shareholder payable initially on January
31,  2003.  The due date of the note also has been  extended  to June 30,  2003.
Payment of both notes is secured by Company revenues.


NOTE 5 - ACCRUED COMPENSATION AND BENEFITS

Accrued  compensation  consists of the following  amounts payable to current and
former employees:

                                                 March 31,        December 31,
                                                    2003              2002
                                                -----------       -----------
     Accrued wages                              $   234,841       $   235,515
     Accrued consulting fees                         30,894            31,737
     Accrued bonuses                                 98,037            95,499
     Accrued vacation pay                            62,915            64,646
                                                -----------       -----------
                                                $   426,687       $   427,397
                                                ===========       ===========

The Company  operated under severe cash flow  difficulties  for extended periods
during 2001 and 2002, prompting its two officers to voluntarily and at their own
discretion  defer  receipt of payment of  significant  portions of their current
wages to reduce the Company's monthly cash requirements.  With the generation of
cash flow from revenues earned under contracts awarded to the Company during the
second half of 2002,  some of the amounts owed to the  Company's  officers  were
repaid.  Since  December 2002, the Company's  chief  financial  officer has been
receiving  his  current  wages,  while the  Company's  chief  executive  officer
continues  to defer a  significant  portion  of his  current  wages.  Such wages
payable to the Company's officers totaled $212,613 as of March 31, 2003.

The continued  deferral of portions of current  wages by the Company's  officers
cannot be expected to continue indefinitely, and the Company will be required to
pay amounts outstanding as soon as cash flow permits. Similarly, the Company has
accumulated unpaid consulting fees, the majority of which amounts are payable to
the individual who serves as the Company's director of business  development and
technical  program  manager on a part-time  basis.  As of March 31,  2003,  this
individual  is owed  $27,859.  The  amount  and  timing of  payments  for unpaid
compensation  owing  to the  Company's  officers  and  this  consultant  will be
determined at the discretion of the Company's officers; however, all such unpaid
compensation  is payable  upon demand,  as these  amounts are not subject to the
terms of the Company's  written  agreement with current and former  employees to
defer payment of portions of their salaries as described in Note 7.

In  December  of each year,  the  Company  awards  bonuses to its  officers  and
employees  with the  stipulation  that payment of such bonuses is to be deferred
until the Board of Directors  determines  that the Company's  cash resources are
sufficient to enable such payments.  In connection  with a private  placement in
March 2002 as detailed in Note 9, the Company paid $22,500 of bonuses accrued as
of  December  31,  2001 and $4,500 of  consulting  fees  accrued as of that date
through the conversion of such amounts to equity.  The amount of accrued bonuses
included in the table above that was payable to the Company's  officers at March
31, 2003 is $72,500.  Payment of accrued bonuses are not subject to the terms of
the  Company's  written  agreement  with  current and former  employees to defer
payment of portions of their salaries as described in Note 7.

The Company's only liability to employees for future compensated absences is for
accrued but unused  vacation pay. The amount of vacation pay earned by employees
is determined by job classification and length of service. The amount of accrued
vacation included in the table above that was payable to the Company's  officers
at March 31, 2003 is $48,856.  Accrued  vacation  compensation  is payable  upon
termination of employment, and such payments are not subject to the terms of the
Company's  written  agreement with current and former employees to defer payment
of portions of their salaries as described in Note 7.


NOTE 6 - CAPITAL LEASE OBLIGATIONS

During the first quarter of 2003 the Company incurred capital lease  obligations
totaling $43,002 in connection with the acquisition of equipment.  The repayment
of a four-year  equipment  lease  obligation in the principal  amount of $38,575
included in this total has been  personally  guaranteed by the  Company's  chief
executive officer.



NOTE 7 - DEFERRED COMPENSATION

In order to help  conserve  the  Company's  limited cash  resources,  all of the
Company's  current  and  former  officers  and  certain of the  Company's  other
employees  for several  years have  voluntarily  deferred  receipt of payment of
significant  portions of their authorized  annual salaries at the request of the
Board of  Directors.  A written  agreement  between  these  individuals  and the
Company  was first  executed  in 1992 in  connection  with an  indispensable  $2
million  private  investment made by a venture capital group in exchange for the
issuance of a new class of convertible  preferred  stock as described in Note 9.
The  individuals  who  are  parties  to this  agreement  have  consented  to the
continued deferral,  as necessary,  of current  compensation and the deferral of
payment of amounts so  accumulated  until the  Company  has  received  licensing
revenue of at least $2 million or at such earlier date as the Board of Directors
determines that the Company's cash flow is sufficient to allow such payment.

Deferred compensation outstanding is payable to the following classifications of
personnel:

                                                  March 31,       December 31,
                                                    2003              2002
                                                -----------       -----------

     Current officers                           $   589,826       $   574,249
     Current employees                               12,504            12,504
     Former officers and other employees            320,103           320,103
                                                -----------       -----------
                                                $   922,433       $   906,856
                                                ===========       ===========

The  conditions  that would  require  repayment of deferred  amounts have yet to
occur,  and it is unlikely  that such  conditions  will occur prior to March 31,
2004.  Accordingly,  such deferred  compensation  is reported  separately in the
accompanying balance sheet as a non-current liability.

At the  conclusion  of a legal  challenge by two former  officers of the Company
initiated  in  1993  demanding  full  payment  of  deferred  salaries  upon  the
termination of their  employment,  in 1996 the Maryland Court of Special Appeals
rejected this demand and ruled that the written agreement to defer  compensation
was a valid and enforceable contract.


NOTE 8 - INCOME TAXES

The  Company  has not  incurred  any  federal or state  income  taxes  since its
inception  due to operating  losses.  At December 31, 2002,  the Company had net
operating loss and capital loss  carryforwards  of  approximately  $12.5 million
available to offset future taxable income. If certain substantial changes in the
Company's  ownership  should occur,  there would be an annual  limitation on the
amount of the carryforwards which can be utilized. Since 1995 net operating loss
carryforwards  aggregating  approximately  $6.6 million have expired unused,  as
have capital loss  carryforwards of approximately  $335,000.  Net operating loss
carryforwards  of  approximately  $1,345,000 and capital loss  carryforwards  of
approximately $365,000 are scheduled to expire at the end of 2003.



NOTE 9 - CAPITAL STOCK

Authorized capital stock

The Company is presently authorized to issue 48 million shares of $.01 par value
common stock and 2 million shares of $.01 par value convertible preferred stock.
All of the  authorized  shares of  preferred  stock,  along  with  common  stock
purchase warrants,  were issued in connection with an indispensable financing of
$2 million received in February 1992 (the "Preferred Stock  Investment")  from a
small number of individuals who qualified as "accredited  investors" pursuant to
Rule 501 of  Regulation  D of the  Securities  Act of 1933  (the  "Act")  and to
Proactive Partners, L.P. and certain of its affiliates ("Proactive"), who became
the largest  beneficial  owner of the  Company's  common  stock by virtue of the
acquisition  of the  convertible  preferred  stock  and  common  stock  purchase
warrants.

The preferred  stock has priority in liquidation  over the common stock,  but it
carries no stated  dividend.  The holders of the  preferred  stock,  voting as a
separate class,  have the right to elect that number of directors of the Company
which  represents a majority of the total  number of  directors.  The  preferred
stock is  convertible  at any time at the option of the holder into common stock
at the rate of $.35 per share of common stock.  As of March 31, 2003, a total of
459,999 shares of preferred  stock had been  converted into 1,314,278  shares of
common stock.


Private placement of common equity

In a private  financing at the end of March 2002,  the Company raised capital of
$60,000,  including $27,000 in cash investments,  $27,000 from the conversion to
equity of accrued liabilities to officers,  employees and consultants,  and cash
proceeds of $6,000 through the issuance of a short-term note that is convertible
to  equity  at the  option  of the  holder.  A total of  360,000  shares  of the
Company's common stock and five-year  warrants to purchase an additional 180,000
shares of common  stock at $.25 per share  were  issued in this  financing,  and
60,000 shares were reserved for future  issuance upon the conversion of the note
payable to common stock and a warrant to purchase common stock.

The offer and sale of these  shares of common  stock and  warrants  to  purchase
shares of common stock  satisfied the  conditions of Rule 506 of Regulation D of
the Act and, as such, were exempt from the registration  requirements of Section
5 of the Act as  transactions  not  involving  any  public  offering  within the
meaning of Section 4(2) of the Act.


Stock options

The Company  maintains a  non-qualified  stock  option plan created in 1987 (the
"Plan") which has made  available for issuance a total of 7.5 million  shares of
common stock. All directors,  full-time employees and consultants to the Company
are eligible for  participation.  Option awards are determined at the discretion
of the  Board of  Directors.  Upon a  change  in  control  of the  Company,  all
outstanding  options  granted to  employees  and  directors  become  vested with
respect to those  options  which have not already  vested.  Options  outstanding
expire at various dates through March 2013.


From  January 1, 2003  through  March 31,  2003,  the Company had the  following
activity in options to purchase shares of common stock under the Plan:


                                            Weighted                Weighted
                                             average      # of       average
                                     # of   exercise      shares    exercise
                                    shares    price    exercisable    price
                                    ------    -----    -----------    -----

Unexercised at January 1, 2003     4,523,058   $.43      4,129,058     $.45
    Granted                          263,415    .25        113,415      .25
    Becoming exercisable
    Exercised
    Lapsed                          (125,000)   .35        (50,000)     .50
                                   ---------             ---------
Unexercised at March 31, 2003      4,661,473   $.41      4,192,473     $.43
                                   =========   ====      =========     ====

Through  December 31, 2002, the Company  accounted for stock-based  compensation
using the intrinsic value method prescribed in Accounting Principles Board (APB)
Opinion No. 25. Under APB No. 25,  compensation  cost is measured as the excess,
if any, of the quoted market price of the  Company's  stock at the date of grant
over the  exercise  price of the  option  granted.  Compensation  cost for stock
options, if any, is recognized ratably over the vesting period.

As of January 1, 2003,  the Company  adopted  Statement of Financial  Accounting
Standards  (SFAS) No. 123 - "Accounting  for  Stock-based  Compensation",  which
provides  for the fair value  based  method of  accounting  to be applied to the
Company's stock option grants and other stock-based compensation. SFAS No. 148 -
"Accounting for Stock-based  Compensation Transition and Disclosure",  issued in
December 2002, amends SFAS No. 123 to provide  alternative methods of transition
for a voluntary  change to the fair value based method of  accounting  for stock
options and other stock-based employee  compensation.  The Company has chosen to
apply the "modified  prospective  method" of SFAS No. 148 pursuant to which fair
value based stock option  compensation  costs for 2003 will be  recognized as if
the  fair  value  based  method  had  been  used to  account  for  all  employee
stock-based awards made in prior periods as well as the current period.

For purposes of  calculating  charges to expense for stock  option  compensation
under SFAS No. 123, the Company has  estimated the grant date fair value of each
option using the Black-Scholes  option pricing model with the following weighted
average  assumptions  for  2003:  volatility  factor of 95%,  average  risk-free
interest rate of 3.8%, zero dividend yield,  and average  expected term of eight
years.  As a result,  for the  three-months  ended March 31,  2003,  the Company
recorded stock option  compensation under SFAS No. 123 totaling $25,666 based on
a weighted  average fair value per share for options granted during 2003,  2002,
2001,  and 2000 of $.17,  $.15,  $.19, and $.37,  respectively.  As was the case
under APB Opinion No. 25, the amount of compensation expense is also credited to
additional paid-in capital.

Had  compensation  cost for options  granted been  determined  in prior  periods
consistent  with the method of SFAS No.  123,  the Company  would have  recorded
additional  compensation  expense of $26,684 for the first quarter of 2002,  and
the Company's net loss and net loss per share for the  three-months  ended March
31, 2002 on a pro forma basis would have been as follows:

      Net loss - as reported                            $125,664
      Net loss - pro forma                              $152,348
      Net loss per share - as reported                     $.006
      Net loss per share - pro forma                       $.007

The  Black-Scholes  valuation model was developed for use in estimating the fair
value of  traded  options  which  have no  vesting  restrictions  and are  fully
transferable,  as opposed  to the type of  compensatory  options  granted by the
Company.  It also requires the input of highly subjective  assumptions,  such as
the expected stock price volatility,  changes in which can materially affect the
fair  value   estimate.   Because  the  options  granted  by  the  Company  have
characteristics  significantly  different  from  those of  traded  options,  the
amounts  calculated  using the Black  Scholes  option  valuation  model,  in the
opinion of management,  do not necessarily  provide a reliable single measure of
the fair value of options granted by the Company.


Common stock reserved for future issuance

At March 31, 2003, a total of 11,516,832 shares of common stock were reserved by
the Company for issuance for the following purposes:


                         Purpose                            # of shares
      ----------------------------------------------        -----------

	Currently exercisable warrants expiring in
         December 2005, exercisable at $.50 per share           387,500
         March 2006, exercisable at $.50 per share              250,000
         April 2006, exercisable at $.50 per share              175,000
         March 2007, exercisable at $.25 per share              180,000
                                                            -----------
                                                                992,500

      Currently exercisable options                           4,192,473
      Granted options becoming exercisable in the future        469,000
      Options available for future grants                     1,402,859
      Conversion of note payable                                 60,000
      Conversion of preferred stock                           4,400,000
                                                            -----------

         Total shares reserved                               11,516,832
									      ===========

NOTE 10 - COMMITMENTS

The Company  occupies  its office and  laboratory  facility on a  month-to-month
basis  under the terms of an  operating  lease  agreement  pursuant to which the
property owner is required to provide thirty days notice if he wants the Company
to vacate the premises.  The lease currently provides for monthly rent of $4,000
and requires the Company to pay all property related expenses.  The Company will
seek to  negotiate  a new  long-term  lease for its  facility  or search  for an
alternative  location in the event that a long-term  agreement cannot be reached
for the  existing  premises.  Management  believes  that the  resolution  of the
uncertainty  with  respect  to the  facility  will not  result in a  significant
interruption in the operations of the Company.



ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL POSITION
                         AND RESULTS OF OPERATIONS


Caution regarding forward-looking statements

Sections of this document,  as well as all publicly  disseminated material about
Sonex Research, Inc. ("Sonex" or the "Company"), contain expressions of beliefs,
expectations, or intentions, in the form of "forward-looking" statements as that
term is defined under  applicable  federal  securities laws. Such statements are
based  on  current  expectations,  estimates,  projections  and  assumptions  by
management with respect to, among other things,  trends  affecting the Company's
financial  condition  or results of  operations  and the impact of  competition.
Words  such  as  "expects",  "anticipates",  "plans",  "believes",  "estimates",
variations of such words, and similar  expressions are intended to identify such
statements  that  include,  but are not limited  to,  projections  of  revenues,
earnings,  cash flows and contract awards. Such  forward-looking  statements are
not guarantees of future performance and involve risks and uncertainties, all of
which are  difficult  to predict and many of which are beyond the control of the
Company.

Forward-looking  statements  contained  herein speak only as of the date of this
report.  The Company  disclaims any  obligation to update these  statements  and
cautions readers not to place undue reliance on such statements.


Risk factors

In order to obtain the benefits of the "safe harbor" provisions under applicable
federal  securities  laws  for  any  "forward-looking"  statements  of the  type
described  previously  under  the  heading  "Caution  Regarding  Forward-Looking
Statements",  the  Company  cautions  shareholders,  investors  and  prospective
investors  about  significant  factors which,  among other things,  have in some
cases  affected the  Company's  actual  results and are in the future  likely to
affect the Company's  actual  results and cause them to differ  materially  from
those expressed in any such forward-looking statements.

Factors  that could  cause  actual  results  to differ  materially  include  the
specific risks listed below. These risks and uncertainties are not the only ones
faced by the Company or that may adversely  affect its  business.  If any of the
following  risks  or  uncertainties  actually  occur,  the  Company's  business,
financial  condition  or results of  operations  could be  materially  adversely
affected.


  |X| ability  to  generate  cash flow from  revenue  or to secure  financing
      necessary  to fund future  operations
  |X| ability to  complete  technology development and demonstration programs,
      demonstrate commercial viability of its technology and execute licensing
      agreements that produce significant  revenue
  |X| ability to maintain and protect the Company's patents  and  proprietary
      information
  |X| ability to attract and retain skilled  personnel
  |X| ability to secure a long-term lease for the Company's existing facility
      or to secure an alternative location
  |X| changes in general economic conditions
  |X| competition from companies which have  substantially  greater financial,
      technical and marketing resources than does the Company


Furthermore,  since its inception in 1980, the Company has generated  cumulative
net  losses  in excess  of $22  million,  and may  continue  to incur  quarterly
operating losses for the foreseeable  future.  Operating results have fluctuated
significantly  in the past on an annual and quarterly basis, and are expected to
continue to fluctuate  significantly from quarter to quarter for the foreseeable
future. The business historically has not generated sufficient cash flow to fund
operations  without  resorting to external sources of capital.  The Company does
not have any bank  financing  arrangements.  Operating  funds  have been  raised
primarily  through  the sale of equity  securities  in both  public and  private
offerings, with revenues also providing limited operating cash.

In the event that funding from  internal and external  sources is  insufficient,
the Company would have to cut back  significantly  its level of spending,  which
could  substantially  curtail the Company's  operations.  These reductions could
have an adverse effect on the Company's  relations with its potential  customers
and government funding sponsors.

The Company's success also depends in significant part on the continued services
of its key technical  and senior  management  personnel.  Losing one or more key
employees,  including for reasons of poor health,  disability,  or death,  could
have a material adverse effect on the Company's business, results of operations,
and  financial  condition.  Due to the expense  involved,  the Company  does not
maintain life  insurance  policies for any of its  employees.  Additionally,  in
order  to avoid  long-term  financial  commitments,  the  Company  does not have
employment agreements with any of its personnel.

Further,  the market  price of the  Company's  Common  Stock  could be  affected
adversely by the substantial  number of shares that are reserved for, and may be
issued in, the future.  As of March 31, 2003,  there were  21,592,669  shares of
Common  Stock  issued and  outstanding,  with an  additional  11,516,832  shares
reserved  for future  issuance  upon the  conversion  of  preferred  stock,  the
exercise of options and warrants, and the conversion of notes payable.


Competition

The  Company  faces   significant   competition  from  the  extensive   research
departments  of the  world's  major  vehicle  and  engine  manufacturers.  These
companies  exercise a bias toward in-house  technologies over those developed by
independent  suppliers.  Competition also comes from several  independent engine
testing  and  consulting  firms  around the world  which are in the  business of
developing engine  technologies.  The Company's  competitors have  substantially
greater  financial,  technical  and marketing  resources  than does the Company.
Accordingly,  the  Company  cannot be sure that it will  have the  resources  or
expertise to compete successfully in the future.

Although the experience and financial  resources of its  competitors  far exceed
those of the Company,  management  believes that the SCS can provide significant
advantages over the competition in terms of low cost, improved performance,  and
simplicity.


Secrecy and non-disclosure

Due to the  highly  competitive  nature  of the  world's  automotive  and  truck
industries,  in connection with its contracts and/or demonstration programs with
such  manufacturers,  Sonex is required to execute joint secrecy and  disclosure
agreements that, in most cases,  expressly prohibit the public disclosure of the
names and other  significant  information about the participants and the current
or  proposed  programs.  Failure  by  Sonex to  maintain  this  strict  level of
confidentiality would jeopardize its relationship with these organizations.


Overview of the Company and its technology

Sonex,  incorporated  in  Maryland  in  1980,  is an  engineering  research  and
development  firm that is  seeking to  commercialize  its  patented  proprietary
technology  (the  "Sonex  Combustion  System",  "SCS"  or  "Ultra  Clean  BurnTM
technology")  for  in-cylinder  control of ignition and combustion in engines of
various types.  The Company was  co-founded in 1980 by Dr. Andrew A. Pouring,  a
former  Professor of Aerospace  Engineering  and Chairman of the  Department  of
Aerospace Engineering at the U.S. Naval Academy. At Sonex, Dr. Pouring conducted
basic  research  into the  principle  of  in-cylinder  control of  ignition  and
combustion,  concentrating  on the piston.  By the late 1980's and early 1990's,
the  development  of the SCS had moved in the  direction  of  chemical/turbulent
enhancement of combustion  through  investigation of the effects of changing the
chemical  characteristics  and  fuel  disbursement  characteristics  within  the
combustion chamber.

The Company seeks to commercialize  its SCS technologies for a variety of engine
applications  for  commercial  and military  use. To date,  Sonex has engaged in
development and demonstration programs with the engine industry and has received
funding  from  the  federal  government  for  further  development  of  the  SCS
technologies.  The Company's  primary  objective is to execute broad  agreements
with engine and parts manufacturers for industrial  production of SCS components
under license from Sonex.

The SCS  technology  for  in-cylinder  control of  ignition  and  combustion  is
designed to

  |X| reduce emissions of diesel engines
  |X| increase fuel mileage of a new  generation of gasoline  engines
  |X| permit gasoline engines to run on safer, kerosene-based "heavy" fuels

The SCS improves the combustion of fuels in engines through design  modification
of the pistons in  four-stroke,  direct  injected (DI),  engines or the cylinder
heads  in  two-stroke,   spark-ignited   (SI),   gasoline   engines  to  achieve
chemical/turbulent  enhancement of combustion. The SCS process for both two- and
four-stroke  engines  achieves  in-cylinder  control of ignition and  combustion
through the chemical/turbulent  enhancement of combustion via combustion chamber
modifications  that change the chemical  characteristics  and fuel  disbursement
characteristics within the combustion chamber.

SCS  reductions  of soot in DI diesel truck  engines  have been  confirmed by an
independent  international  engine  consulting firm.  Evidence to date indicates
that the SCS is a significant new engine design  variable,  and that the synergy
of the SCS in combination with exhaust gas  recirculation  (EGR) can help reduce
exhaust  aftertreatment  requirements to meet future regulatory  standards.  The
Company believes that SCS diesel engine designs should provide reductions in the
cost and complexity of future exhaust aftertreatment systems.

Sonex also is seeking to show the  technical  feasibility  of achieving  reduced
fuel consumption while lowering emissions in a new class of DI gasoline engines,
yet overcoming the safety concern that vehicles would need to be reduced in size
and weight to improve  fuel  mileage.  A new branch of the SCS  focusing  on the
control of ignition may, with further  development,  enable DI gasoline  engined
automobiles,  currently  manufactured  and sold only in markets outside the U.S.
due to emissions considerations, to become emissions compliant in the U.S. while
providing  fuel  consumption  benefits.  In  addition,  the  evolution of hybrid
gasoline  and  electric  powered  vehicles  could be  accelerated  since a major
improvement in engine fuel mileage would provide  opportunities  for tradeoff of
vehicle weight versus power.

An SCS process for the  conversion  of reliable,  lightweight,  SI,  two-stroke,
gasoline engines to start and operate on  kerosene-based  "heavy" fuels has been
applied  successfully  in a variety  of  applications  such as  small,  remotely
controlled  military unmanned aerial vehicles (UAVs).  The military now requires
such  engines  to  operate  on less  volatile  heavy  fuels to reduce the hazard
associated  with  gasoline,  making heavy fuel engines  (HFEs) more suitable for
applications   where  gasoline  storage  and  use  are  undesirable.   Potential
applications of the SCS heavy fuel conversion process can be expanded to a range
of military  and  commercial  uses.  Sonex is also  developing a process for the
heavy fuel conversion of SI four-stroke gasoline engines, and has recently begun
investigating  the synergy of SCS technology with rotary  engines.  In addition,
Sonex is examining the potential, through cooperation with one or more companies
which have complementary technologies and production capabilities, of becoming a
supplier of small HFEs to military and commercial markets.

As of March  31,  2003,  the  Company  has  seven  full-time  employees  and one
part-time  employee,  and engages the  part-time  services of a  consultant  who
serves as its  director  of  business  development  and  manager  of  government
programs.  The Company also engages the services of several other  technical and
business  consultants as needed.  The Company has never  experienced a strike or
work stoppage, and believes its relations with its employees are good.


Business Strategy

The Company has come to realize that it lacks the  resources  to address  issues
such as piston manufacturing  processes,  durability testing, and cost analysis.
Present  Sonex  technology  development  is being  supported by U.S.  Government
funding, and the Company is also seeking committed business partners for further
technical  development  and  marketing  of the various SCS engine  applications.
Sonex believes that having one or more such partners experienced in dealing with
the  engine  and  automotive   industries  on   state-of-the-art   technological
developments  may  accelerate  commercial  acceptance  of  the  SCS  technology.
Development  efforts taking place currently under government  contracts to Sonex
could  facilitate  participation  by the engine and  automotive  industries  and
thereby  accelerate  commercialization  potential of the patented SCS technology
for in-cylinder control of ignition and combustion.

In January 2003 the Company  engaged the Annapolis,  Maryland  consulting  group
Paradigm Technologies, LLC ("Paradigm") to assess the Company's technologies and
business  model and suggest  approaches  for strategic  alliances and additional
market introductions for both commercial and military  applications.  Presently,
Company management and Paradigm are pursuing a number of initiatives. One of the
first  goals is to secure  cooperation  with one or more  companies  which  have
technologies complementary to the Sonex processes.  Additionally,  Paradigm will
also seek  further  funding  for Sonex to conduct  technology  development  work
necessary  for  addressing  commercialization  issues.  The  Company's  Board of
Directors and  management,  assisted by Paradigm,  are assessing other strategic
alternatives,  which may  include a sale of part or all of the  Company or other
corporate  transactions,  to permit Sonex shareholders to maximize the return on
their investments.


Primary SCS design modifications

The SCS technology for four-stroke DI engines improves the process of combustion
through a  combination  of  chemical  and fluid  dynamic  effects  that occur by
modifying the engine's  combustion  chamber and the processes  occurring  within
that  chamber.  The SCS  processes  for DI engines  change only a single  engine
component (the piston) while introducing no additional parts and are self-driven
by the combustion  process.  Patented SCS piston designs for four-stroke engines
integrate  cavities  called  micro-chambers  (MCs)  which form a ring around the
piston bowl,  with each MC  positioned  with respect to each spray from the fuel
injector of a DI engine.  The MCs are  designed  to function  either as chemical
reactors  or  reservoirs,  depending  on the  specific  design  needs,  and  are
connected to the piston bowl by vents. For soot reduction,  the reservoirs/vents
are placed to increase  turbulence,  while for enhanced ignition the MCs produce
highly active  chemical  species from a fraction of the fuel-air charge that are
expelled on the intake  stroke of low  compression  ratio DI engines to fumigate
incoming air and serve as an ignition source.

The SCS process for the  conversion of  lightweight,  SI,  two-stroke,  gasoline
engines introduces  patented features which enable the combustion of heavy fuels
through  design  modification  of the  cylinder  heads to  achieve a  chemically
enhanced  combustion  process  while  still  relying  on the  spark to  initiate
combustion.  Sonex uses a machined  cylinder head and combustion  chamber insert
housing the proprietary SCS technology, and a glow plug-based fuel vaporizer for
cold  starting.  For engines  that have the  cylinder  head and  cylinder in one
single  casting,  the stock cylinder head is removed and the remaining  cylinder
casting is decked and  machined for  cylinder  head  screws.  The SCS heavy fuel
conversion  maintains the gasoline  engine's stock carburetion or fuel injection
system, intake and exhaust systems, spark ignition system, compression ratio and
weight. The SCS starting system uses  commercial-off-the-shelf 12V glow plugs to
directly  vaporize  the heavy fuel for cold  starting.  Once the engine has been
started, the starting system is disabled.


Current Funded Projects

The Company seeks to commercialize  its SCS technologies for a variety of engine
applications  for  commercial  and military  use. To date,  Sonex has engaged in
development and demonstration programs with the engine industry and has received
funding  from  the  federal  government  for  further  development  of  the  SCS
technologies.

The next few paragraphs  provide an overview of the primary  initiatives  taking
place at Sonex.  Additional  detailed  information can be found in the Company's
December 31, 2002 Annual Report on Form 10-KSB.


                                DARPA

In the fourth quarter of 2002 the Company was awarded a $744,246 contract by the
U.S. Defense Advanced  Research  Projects Agency (DARPA) to begin the design and
development of a heavy fuel conversion process for a gasoline  automotive engine
for potential use in a developmental unmanned aerial vehicle (UAV). This project
focuses on the SCS Stratified Charge,  Radical Ignition (SCRI)  application,  an
unthrottled,  low compression ratio, sparkless,  compression ignition process at
gasoline  compression  ratios.  The primary objective of the DARPA program is to
transfer  the SCS SCRI heavy fuel design  achieved in the Sonex  single-cylinder
laboratory  engine  to  a  modern  six-cylinder,   gasoline  automotive  engine,
eliminate  the spark  ignition  system,  and  produce  the same power the engine
originally  produced on gasoline.  As of March 31, 2003,  Sonex has  completed a
design review with DARPA and is progressing to engineer the hardware for the SCS
conversion.  Suppliers  have been engaged and are  responsive  to this  project.
Completion of this project is expected in late 2003 or early 2004.

Outcomes from this program could validate the SCRI  technology  for  in-cylinder
control of ignition  and  combustion  that could be applied  later to a gasoline
powered  version.  The  duration  of  demonstration   projects  with  automotive
manufacturers   could  be  reduced   since  the   sparkless   SCRI  process  can
advantageously  employ the centrally  located spark plug hole of most production
4-valve per cylinder engines for the installation of the injector.

In  addition,   the  Company   believes  the   availability   of  the  resultant
multi-cylinder,  four-stroke heavy fuel engine from a successful  outcome of the
DARPA project could lead to use in other military  engine  programs,  as well as
having  potential for use in the commercial  marine market in pleasure boats for
which a  diesel  fueled  engine  would  be a safer  alternative  to the  current
gasoline engines which too often result in dangerous onboard fires.


                                 DOE

In the fourth  quarter of 2002 the Company  received a subcontract  from Compact
Membrane  Systems,  Inc.  (CMS) for $458,862,  of which  $100,000 is cost-shared
(funded) by Sonex.  CMS is a prime  contractor  for a U.S.  Department of Energy
(DOE),  Small Business  Innovation  Research (SBIR)  Program,  Phase II project.
Sonex and CMS are evaluating the diesel engine emissions  reduction potential of
combining the patented piston-based, SCS technology and the CMS polymer membrane
technology  for the addition of nitrogen  enriched  air (NEA) to the  combustion
process.  In April 2003 Sonex took delivery of the advanced research  automotive
diesel engine to be used for the testing. The engine, which is DOE property,  is
a state-of-the-art,  three-cylinder, direct injected, turbo-charged,  automotive
diesel engine  developed by a major  international  vehicle  manufacturer in the
joint U.S. government and automotive industry funded PNGV (Partnership for a New
Generation Vehicle) program.

Early  stages of the Phase II  project  will  focus on the  emissions  reduction
capabilities  of  the  SCS  pistons  separately,  while  subsequent  testing  in
combination   with  the  NEA  membrane  will   demonstrate   the  viability  for
commercialization  of the synergy of SCS  configurations  and the CMS membranes.
This  program  would  provide  SCS  in-cylinder  emissions  reduction  data on a
multi-cylinder  diesel  engine as a means for  diesel  engine  manufacturers  to
evaluate the potential for SCS designs,  alone and in  combination  with the NEA
membrane,  to reduce the cost and  complexity of future  exhaust  aftertreatment
systems.  While the entire  project is not expected to be completed  until 2004,
testing results on the SCS pistons alone may be available later this year.


                              SAIC

In the third  quarter  of 2002 the  Company  received a  subcontract,  initially
funded for $200,000 and later increased to $281,947,  from Science  Applications
International   Corporation   (SAIC),   a  large  Department  of  Defense  prime
contractor.  Sonex was  tasked to  conduct  a survey of  commercially  available
two-stroke,  spark ignited, gasoline engines of approximately 72 horsepower and,
jointly with SAIC, select a candidate engine for a "best efforts" SCS conversion
to start and  operate on heavy fuels for use in a UAV weapon  system.  SAIC also
awarded a subcontract to a competing firm to develop a heavy fuel conversion for
a  rotary  engine  already  in  production.   SAIC  and  its  military   sponsor
subsequently  increased the targeted  horsepower  requirement  to 100. Sonex and
SAIC together selected a candidate gasoline engine,  not yet in production,  for
conversion to heavy fuel.

Due to  deficiencies  found in operating  the  candidate  engine on gasoline and
concurrent fuel consumption  problems experienced by the competing rotary engine
operating on heavy fuel,  the military  sponsor  recently  expressed a desire to
have Sonex work with the competing rotary engine developer to focus on improving
the fuel  consumption  of the rotary  heavy fuel  engine.  This joint  effort is
expected to be formalized during the second quarter of 2003.


Financial position and liquidity

The Company  operated under severe cash flow  difficulties  for extended periods
during 2001 and 2002, prompting its two officers to voluntarily and at their own
discretion  defer  receipt of payment of  significant  portions of their current
wages to reduce the Company's monthly cash requirements.  With the generation of
cash flow from revenues earned under contracts awarded to the Company during the
second half of 2002,  some of the amounts owed to the  Company's  officers  were
repaid.  Since  December 2002, the Company's  chief  financial  officer has been
receiving  his  current  wages,  while the  Company's  chief  executive  officer
continues  to defer a  significant  portion  of his  current  wages.  Such wages
payable to the Company's officers totaled $212,613 as of March 31, 2003.

The continued  deferral of portions of current  wages by the Company's  officers
cannot be expected to continue indefinitely, and the Company will be required to
pay amounts outstanding as soon as cash flow permits. Similarly, the Company has
accumulated unpaid consulting fees, the majority of which amounts are payable to
the individual who serves as the Company's director of business  development and
technical  program  manager on a part-time  basis.  As of March 31,  2003,  this
individual  is owed  $27,859.  The  amount  and  timing of  payments  for unpaid
compensation  owing  to the  Company's  officers  and  this  consultant  will be
determined at the discretion of the Company's officers; however, all such unpaid
compensation  is payable  upon demand,  as these  amounts are not subject to the
terms of the Company's  written  agreement with current and former  employees to
defer  payment of  portions  of their  salaries  as  described  in Note 7 to the
accompanying unaudited financial statements.

As of March 31, 2003, the Company had available cash and equivalents of $109,635
and accounts  receivable of $23,601.  The Company  historically  has derived the
majority of its revenues from  engineering and development  funding  provided by
established  companies  willing to assist the Company in the  development of its
SCS technology and, more recently,  from government  sources.  In 2002, however,
revenues  increased  substantially,  providing  cash to fund the majority of the
Company's operating expenditure  requirements for the year. All of the Company's
revenue for 2002 and 2003 has been derived from  development  and  demonstration
contracts  issued by a United States  Government or Department of Defense agency
or  prime  contractor.  In 2003  revenues  from  development  and  demonstration
contracts are again  expected,  although  there can be no assurance,  to provide
most of the cash necessary to fund operations.

Based upon  available  resources,  current and projected  spending  levels,  and
expected revenue from current and anticipated contracts, management believes the
Company will have  sufficient  capital to fund operations  through  December 31,
2003. The Company's prospects beyond that date are dependent upon its ability to
enter into significant  funded contracts for the further  development of its SCS
technology,  establish  joint  ventures  or  strategic  partnerships  with major
industrial concerns,  or secure a major capital infusion.  There is no assurance
that the Company will be able to achieve these objectives.

In the event  sufficient  funding is not  available  through the  generation  of
revenues  or from  external  sources,  the Company  would have to  substantially
reduce  the level of its  operations.  Such a  reduction  could  have an adverse
effect on the Company's relationships with government funding sources, strategic
partners and potential customers.

The accompanying unaudited financial statements have been prepared assuming that
the Company will continue as a going concern,  which contemplates  continuity of
operations,  realization  of  assets  and  satisfaction  of  liabilities  in the
ordinary course of business.  The propriety of use of the going concern basis is
dependent upon, among other things, the Company's ability to generate sufficient
revenue and ultimately achieve profitable operations.  These uncertainties raise
substantial  doubt about the Company's  ability to continue as a going  concern.
The accompanying financial statements do not include any adjustments relating to
the  recoverability  of the carrying amounts of recorded assets or the amount of
liabilities that might result from the outcome of these uncertainties.


Results of operations

A net loss of  $101,738  was  recorded  for the first three  months of 2003,  as
compared  to  $125,664  for the  corresponding  period in 2002,  a  decrease  of
$23,926,  or 19%.  With the award of several  significant  contracts  during the
second half of 2002,  revenue  increased nearly five-fold in the current quarter
versus the prior year,  with  related  increases  in expenses to support the new
work.

[Note: In order to conform to the classifications  used in 2003, certain amounts
for 2002  presented in the prior  year's  financial  statements  as research and
development  expenses have been reclassified  below to cost of revenue.  The net
loss for each period does not change as a result of these reclassifications.]








       Revenue and cost of revenue:


                                                     Three months ended
                                                          March 31,
                                                -----------------------------
                                                    2003              2002
                                                ------------     ------------

       Defense/government revenue               $    174,329     $     35,870
                                                ============     ============

       Cost of revenue                          $    108,426     $     32,998
                                                ============     ============


Revenue  increased  substantially  from the first  quarter  of 2002 to the first
quarter of 2003, as during the second half of 2002 the Company was awarded three
significant  contracts and subcontracts from branches of the U.S. government and
Department of Defense (DoD) and/or their prime  contractors.  The following is a
listing of the three major new projects, descriptions of which appear earlier in
this report.

      Subcontract  awarded by  Science  Applications  International  Corporation
      (SAIC),  a large DoD prime  contractor.  Awarded  third  quarter  of 2002.
      Initial  funding of $200,000,  later  increased  by $81,947.  Completed in
      first quarter of 2003.

      Prime contract  awarded by the Defense Advanced  Research  Projects Agency
      (DARPA).  Awarded  fourth  quarter of 2002.  Total  funding  of  $744,246.
      Completion expected in late 2003 or early 2004.

      Subcontract  awarded by Compact  Membrane  Systems,  Inc.  (CMS) under its
      prime  contract from the U.S.  Department of Energy (DOE).  Awarded fourth
      quarter of 2002.  Total award to Sonex of $458,862,  of which  $100,000 is
      cost-shared (funded) by Sonex. Completion expected in 2004.

Cost of Revenue  primarily  consists of direct  labor  charges and other  direct
expenditures,  including those for consulting  services,  attributable to funded
programs,  as well as  allocated  fringe  benefits,  payroll  taxes,  and  labor
overhead  charges.  Cost of Revenue as a percentage of total  revenue  decreased
from 92% in 2002 to 62% in 2003,  as cost  overruns were incurred by the Company
on the small contracts in place during the first quarter of 2002.


       Research and development (R&D) expenses:

									Three months ended
                                                          March 31,
                                                -----------------------------
                                                    2003              2002
                                                ------------     ------------

 Employee compensation, taxes & benefits        $    103,072     $     60,853
 Consulting fees                                      30,955            6,073
 Other expenses                                       49,445           30,126
                                                ------------     ------------

 Total R&D expenses                                  183,472           97,052

 Less amounts classified as cost of revenue         (108,426)         (32,998)
                                                ------------     ------------

 Net R&D expenses                               $     75,046     $     64,054
                                                ============     ============


The following  analysis is based on a comparison of total R&D expenses as listed
above before deduction of amounts classified as cost of revenue.

Total R&D expenses for the first three months of the year  increased by $86,420,
or 89%,  from  2002 to  2003.  The  largest  component,  employee  compensation,
increased  by $42,219,  or 69%, as  additional  personnel  were hired during the
second half of 2002 to work on the new contracts received by the Company. During
the first quarter of 2003, the Company had seven  full-time  employees,  whereas
there were only three by the end of the first quarter of 2002.  Consulting  fees
also increased significantly due to the efforts needed on the new contracts. The
increase in other expenses  primarily  relates to higher  purchases of parts and
supplies to support the new contracts.


       General and administrative (G&A) expenses:


                                                     Three months ended
                                                          March 31,
                                                -----------------------------
                                                    2003              2002
                                                ------------     ------------

  Employee compensation, taxes & benefits       $     50,401     $     28,024
  Consulting fees                                     18,380           16,266
  Professional fees                                   11,526           11,283
  Other expenses                                       9,968            8,133
                                                ------------     ------------

  Total G&A expenses                            $     90,275     $     63,706
                                                ============     ============


Total G&A expenses for the first three months of the year  increased by $26,569,
or 42%,  from  2002 to  2003.  The  largest  component,  employee  compensation,
increased by $22,377,  or 80%, for a number of reasons.  The largest  factor was
the recording of $14,528 in charges for stock option compensation in 2003 as the
Company  changed  its  method of  accounting  for  stock-based  compensation  as
described in Note 9 to the accompanying  unaudited  financial  statements.  This
amount consists of the  amortization  over the related vesting period of charges
related to option  grants made in prior years as well as in the current  period.
The other increases in employee  compensation  reflect an increase in the salary
(before  deferral) of the Company's chief financial officer effective January 1,
2003 and the costs for a part-time administrative assistant beginning in January
2003.



ITEM 3.       CONTROLS AND PROCEDURES

The Company's chief executive officer and chief financial officer have evaluated
the effectiveness of the Company's  disclosure  controls and procedures (as such
term is defined in Rules 13a-14(c) and 15d-14(c)  under the Securities  Exchange
Act of 1934) as of an evaluation date within 90 days prior to the filing date of
this  Quarterly  Report  on Form  10-QSB.  Based on such  evaluation  they  have
concluded that, as of the evaluation date, the Company's disclosure controls and
procedures are effective to ensure that information  required to be disclosed in
reports that the Company  files or submits  under the Exchange Act, is recorded,
processed, summarized and reported in a timely manner.

Since the  evaluation  date  referred to above,  there have been no  significant
changes  in the  Company's  internal  controls  or in other  factors  that could
significantly affect such controls.




                           PART II - OTHER INFORMATION


ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K


(a)   Exhibits.

          3    Articles of Incorporation  and Bylaws (as amended) - Incorporated
               by reference to the  Company's  Annual  Report on Form 10-KSB for
               the year ended December 31, 1992.
          4    Instruments defining the rights of security holders (contained
               in Exhibit 3 hereof).
       10.1    1987 Non-Qualified  Stock Option Plan, as amended - Incorporated
               by reference to the Company's  Registration Statement No.
               33-34520 on Form S-8.
         24    Power of Attorney - Incorporated by reference to the Company's
               Annual Report on Form 10-KSB for the year ended December 31,
   1998.
         99    Certification of Form 10-QSB for the quarterly period ended March
               31, 2003 pursuant to 18 U.S.C.  Section 1350, as adopted pursuant
               to Section 906 of the Sarbanes-Oxley Act of 2002.


(b)   Reports on Form 8-K.

      During the first quarter of 2003, the Company filed the following Current
      Reports on Form 8-K:

		On March 27, 2003, to disclose the resignation of the Chairman of
		its Board of Directors.






                                   SIGNATURES

     In accordance  with the  requirements  of the Exchange Act, the  Registrant
caused this report to be signed on its behalf by the  undersigned,  thereto duly
authorized.

                                 SONEX RESEARCH, INC.
                                  (Registrant)


                                            /s/ George E. Ponticas
                                         ----------------------------
                                by:      George E. Ponticas
                                         Chief Financial Officer


May 20, 2003




                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
            Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002


I, Andrew A. Pouring, Chief Executive Officer, certify that:

1.      I have reviewed this Quarterly Report on Form 10-QSB of Sonex Research,
        Inc. (the "Company").

2.      Based on my knowledge, this report does not contain any untrue statement
        of a material  fact or omit to state a material  fact  necessary to make
        the  statements  made,  in light of the  circumstances  under which such
        statements  were made, not misleading with respect to the period covered
        by this report;

3.      Based on my knowledge,  the financial  statements,  and other  financial
        information  included in this  report,  fairly  present in all  material
        respects the financial  condition,  results of operations and cash flows
        of the Company as of, and for, the periods presented in this report;

4.      The  Company's  other  certifying  officer  and  I are  responsible  for
        establishing  and  maintaining  disclosure  controls and  procedures (as
        defined in  Exchange  Act Rules  13a-14 and  15d-14) for the Company and
        have:

        a)   designed  such  disclosure  controls and  procedures to ensure that
             material  information  relating  to  the  Company,   including  its
             consolidated  subsidiaries,  if any,  is made known to us by others
             within those entities, particularly during the period in which this
             report is being prepared;
        b)   evaluated the  effectiveness of the Company 's disclosure  controls
             and procedures as of a date within 90 days prior to the filing date
             of this report (the "Evaluation Date"); and
        c)   presented in this report our conclusions about the effectiveness of
             the disclosure  controls and procedures  based on our evaluation as
             of the Evaluation Date;

5.      The Company's  other  certifying  officer and I disclosed,  based on our
        most  recent  evaluation,  to the  Company  's  auditors  and the  audit
        committee of Company 's board of directors  (or persons  performing  the
        equivalent functions):

        a)   all significant deficiencies in the design or operation of internal
             controls  which  could  adversely  affect the Company 's ability to
             record,  process,  summarize  and  report  financial  data and have
             identified  for the Company 's auditors any material  weaknesses in
             internal controls; and
        b)   any fraud,  whether or not material,  that  involves  management or
             other  employees  who have a  significant  role in the  Company  's
             internal controls.

6.      The  Company's  other  certifying  officer and I have  indicated in this
        report whether there were significant changes in internal controls or in
        other  factors  that  could   significantly   affect  internal  controls
        subsequent  to the date of our most  recent  evaluation,  including  any
        corrective actions with regard to significant  deficiencies and material
        weaknesses.


Dated: May 20, 2003

        /s/ Andrew A. Pouring
        ----------------------
        Andrew A. Pouring
        Chief Executive Officer



                      CERTIFICATION OF CHIEF FINANCIAL OFFICER
              Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002


I, George E. Ponticas, Chief Financial Officer, certify that:

1.      I have reviewed this Quarterly Report on Form 10-QSB of Sonex Research,
        Inc. (the "Company").

2.      Based on my knowledge, this report does not contain any untrue statement
        of a material  fact or omit to state a material  fact  necessary to make
        the  statements  made,  in light of the  circumstances  under which such
        statements  were made, not misleading with respect to the period covered
        by this report;

3.      Based on my knowledge,  the financial  statements,  and other  financial
        information  included in this  report,  fairly  present in all  material
        respects the financial  condition,  results of operations and cash flows
        of the Company as of, and for, the periods presented in this report;

4.      The  Company's  other  certifying  officer  and  I are  responsible  for
        establishing  and  maintaining  disclosure  controls and  procedures (as
        defined in  Exchange  Act Rules  13a-14 and  15d-14) for the Company and
        have:

        a)   designed  such  disclosure  controls and  procedures to ensure that
             material  information  relating  to  the  Company,   including  its
             consolidated  subsidiaries,  if any,  is made known to us by others
             within those entities, particularly during the period in which this
             report is being prepared;
        b)   evaluated the  effectiveness of the Company 's disclosure  controls
             and procedures as of a date within 90 days prior to the filing date
             of this report (the "Evaluation Date"); and
        c)   presented in this report our conclusions about the effectiveness of
             the disclosure  controls and procedures  based on our evaluation as
             of the Evaluation Date;

5.      The Company's  other  certifying  officer and I disclosed,  based on our
        most  recent  evaluation,  to the  Company  's  auditors  and the  audit
        committee of Company 's board of directors  (or persons  performing  the
        equivalent functions):

        a)   all significant deficiencies in the design or operation of internal
             controls  which  could  adversely  affect the Company 's ability to
             record,  process,  summarize  and  report  financial  data and have
             identified  for the Company 's auditors any material  weaknesses in
             internal controls; and
        b)   any fraud,  whether or not material,  that  involves  management or
             other  employees  who have a  significant  role in the  Company  's
             internal controls.

6.      The  Company's  other  certifying  officer and I have  indicated in this
        report whether there were significant changes in internal controls or in
        other  factors  that  could   significantly   affect  internal  controls
        subsequent  to the date of our most  recent  evaluation,  including  any
        corrective actions with regard to significant  deficiencies and material
        weaknesses.


Dated: May 20, 2003

        /s/ George E. Ponticas
        ----------------------
        George E. Ponticas
        Chief Financial Officer




                                     EXHIBIT 99

                              CERTIFICATION PURSUANT TO
                   18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                    SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Quarterly  Report of Sonex  Research,  Inc. (the
"Company")  on Form 10-QSB for the quarter  ending March 31, 2003, as filed with
the Securities and Exchange  Commission on the date hereof (the  "Report"),  the
undersigned certify, pursuant to and for the purposes of 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


     (1) The Report fully  complies  with the  requirements  of Section 13(a) or
         15(d) of the Securities Exchange Act of 1934; and

     (2) The  information  contained  in the  Report  fairly  presents,  in all
         material respects, the financial condition and results of operations
         of the Company.




                               SONEX RESEARCH, INC.



         /s/ Andrew A. Pouring                     /s/ George E. Ponticas
         ---------------------                     ----------------------
         Andrew A. Pouring                         George E. Ponticas
         Chief Executive Officer                   Chief Financial Officer



May 20, 2003